StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
31
Publishing Date
2021 - 09 - 20
31
Sector
Communications
1
Finance
1
Health care and social assistance
1
Health technology
25
Manufacturing
3
Tags
Alliances
2
Animals
1
Ath434
1
Biocanada
1
Biomarkers
1
Biotech-bay
2
Biotech-beach
2
Biotechnology
1
Cancer
3
Car-t
1
Clinical-trials-phase-ii
1
Collaboration
2
Conference
7
Contract
1
Covid
1
Covid-19
1
Cudetaxestat
1
Defense
1
Disease
1
Drug
2
Europe
1
Events
6
Fibrosis
1
Growth
1
Huntington
1
Huntington’s disease
1
Leukemia
1
Lung cancer
2
Money
1
N/a
13
Nivolumab
1
Offering
1
Parkinson
1
Patent
1
People
2
Phase 1
3
Phase 1b
1
Phase 2
2
Phase 2b
1
Positive
2
Pre-clinical
1
Preclinical
1
Presentation
8
Research
3
Results
3
Solid tumors
1
Test
1
Therapeutics
6
Therapy
3
Topline
1
Trial
1
Vaccine
1
Entities
Allogene therapeutics, inc.
1
Alterity therapeutics limited
1
American international group, inc.
1
Amicus therapeutics, inc.
1
Aprea therapeutics, inc.
1
Arrival
1
Avalo therapeutics inc
1
Brainstorm cell therapeutics inc.
1
Celularity inc - class a
2
Chinook therapeutics, inc.
1
Cyteir therapeutics inc
1
Dyne therapeutics, inc.
1
Entasis therapeutics holdings inc.
1
Fate therapeutics, inc.
1
Fulcrum therapeutics, inc.
1
Galapagos nv
1
Global blood therapeutics, inc.
1
Johnson & johnson
1
Lineage cell therapeutics, inc.
1
Lyra therapeutics, inc.
1
Medicenna therapeutics corp.
1
Mirati therapeutics, inc.
3
Onconova therapeutics, inc.
1
Oncternal therapeutics, inc.
2
Orange
1
Ptc therapeutics, inc.
1
Rapt therapeutics, inc.
2
Tg therapeutics, inc.
1
Uniqure n.v.
1
Viridian therapeutics inc
1
Vyne therapeutics inc.
1
Symbols
AIG
1
ALLO
1
APRE
1
ARVL
1
ATHE
1
AVTX
1
BCLI
1
CELU
2
CYT
1
DYN
1
ETTX
1
FATE
1
FNCTF
1
FOLD
1
FULC
1
GBT
1
GLPG
1
JNJ
1
KDNY
1
LCTX
1
LYRA
1
MDNA
1
MRTX
3
ONCT
2
ONTX
1
PTCT
1
QURE
1
RAPT
2
TGTX
1
VRDN
1
VYNE
1
Exchanges
Amex
1
Nasdaq
29
Nyse
2
Crawled Date
2024 - 04 - 09
40
2024 - 03 - 05
44
2024 - 01 - 08
49
2024 - 01 - 04
46
2024 - 01 - 03
40
2024 - 01 - 02
42
2023 - 11 - 13
43
2023 - 11 - 09
63
2023 - 11 - 07
52
2023 - 11 - 06
44
2023 - 11 - 02
50
2023 - 11 - 01
59
2023 - 10 - 31
46
2023 - 10 - 30
38
2023 - 10 - 04
47
2023 - 09 - 11
38
2023 - 09 - 07
38
2023 - 09 - 06
51
2023 - 09 - 05
62
2023 - 08 - 14
41
2023 - 08 - 10
42
2023 - 08 - 03
43
2023 - 06 - 01
56
2023 - 05 - 15
44
2023 - 05 - 11
58
2023 - 05 - 10
39
2023 - 05 - 09
45
2023 - 05 - 04
46
2023 - 05 - 03
38
2023 - 05 - 02
39
2023 - 05 - 01
69
2023 - 04 - 27
37
2023 - 03 - 15
39
2023 - 03 - 07
49
2023 - 03 - 06
39
2023 - 03 - 01
47
2023 - 02 - 28
41
2023 - 02 - 09
42
2023 - 02 - 02
38
2022 - 11 - 14
38
2022 - 11 - 10
38
2022 - 11 - 03
42
2022 - 03 - 01
44
2022 - 01 - 04
38
2021 - 12 - 13
41
2021 - 11 - 15
42
2021 - 11 - 12
40
2021 - 11 - 10
45
2021 - 11 - 09
40
2021 - 10 - 07
40
2021 - 09 - 13
41
2021 - 09 - 07
40
2021 - 05 - 06
38
2021 - 04 - 27
39
2021 - 03 - 11
39
2021 - 03 - 04
49
2020 - 12 - 15
45
2020 - 12 - 03
67
2020 - 12 - 02
39
2020 - 12 - 01
55
Crawled Time
12:00
8
12:15
1
13:00
3
13:15
6
14:00
3
14:15
1
15:00
5
20:00
2
21:00
2
Source
www.biospace.com
18
www.fatetherapeutics.com
1
www.globenewswire.com
6
www.prnewswire.com
5
www.vynetherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
crawled date :
2021 - 09 - 20
save search
PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1 Study for Huntington's Disease Program
Published:
2021-09-20
(Crawled : 21:00)
- prnewswire.com
PTCT
|
$25.19
-0.4%
-0.4%
670K
|
Health Technology
|
-39.19%
|
O:
0.26%
H:
5.28%
C:
4.48%
huntington
disease
phase 1
results
conference
phase 2
huntington’s disease
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
Published:
2021-09-20
(Crawled : 21:00)
- globenewswire.com
APRE
|
$5.85
-1.29%
2.3K
|
Health Technology
|
20.62%
|
O:
1.86%
H:
2.23%
C:
-5.47%
solid tumors
phase 1
trial
Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Published:
2021-09-20
(Crawled : 20:00)
- globenewswire.com
VRDN
|
$15.1
0.07%
0.07%
660K
|
Health Care and Social Assistan...
|
33.13%
|
O:
10.63%
H:
10.85%
C:
0.56%
offering
584MP, Contracts Administrator
Published:
2021-09-20
(Crawled : 20:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-91.99%
|
O:
0.71%
H:
4.82%
C:
0.66%
contract
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021
Published:
2021-09-20
(Crawled : 15:00)
- prnewswire.com
ATHE
|
$1.98
-3.42%
-3.54%
120K
|
Health Technology
|
-81.69%
|
O:
-3.08%
H:
10.32%
C:
0.79%
presentation
parkinson
ath434
biomarkers
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Published:
2021-09-20
(Crawled : 15:00)
- biospace.com/
ARVL
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.78%
|
O:
-3.65%
H:
0.0%
C:
0.0%
covid
animals
test
vaccine
defense
covid-19
RAPT Therapeutics to Present at the 2021 Cantor Virtual Healthcare Conference
Published:
2021-09-20
(Crawled : 15:00)
- globenewswire.com
RAPT
|
$8.01
-1.48%
-1.5%
710K
|
Health Technology
|
-79.4%
|
O:
-2.51%
H:
1.3%
C:
-6.68%
conference
GBT Announces Participation at the Cantor Global Healthcare Conference
Published:
2021-09-20
(Crawled : 15:00)
- globenewswire.com
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
144.31%
|
O:
-2.57%
H:
2.12%
C:
-0.77%
conference
Chinook Therapeutics to Present at Upcoming Investor Conferences
Published:
2021-09-20
(Crawled : 15:00)
- globenewswire.com
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
225.46%
|
O:
-1.21%
H:
3.18%
C:
-1.71%
conference
presentation
therapeutics
Mirati Therapeutics Announces Long-term Survival Results from an Exploratory Analysis of Sitravatinib plus Nivolumab in Patients with Non-squamous Non-Small Cell Lung Cancer Who are Resistant to Checkpoint Inhibitors
Published:
2021-09-20
(Crawled : 14:15)
- biospace.com/
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-65.56%
|
O:
0.78%
H:
11.36%
C:
3.1%
lung cancer
results
cancer
nivolumab
RAPT Therapeutics to Present RPT193 Phase 1b Data at 30th European Academy of Dermatology and Venereology Congress
Published:
2021-09-20
(Crawled : 14:00)
- biospace.com/
RAPT
|
$8.01
-1.48%
-1.5%
710K
|
Health Technology
|
-79.4%
|
O:
-2.51%
H:
1.3%
C:
-6.68%
europe
phase 1
phase 1b
phase 2b
Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 ProgramPatent covers the use of IL-2 Superkines such as MDNA11 to treat a wide range of specified cancer types
Published:
2021-09-20
(Crawled : 14:00)
- biospace.com/
MDNA
|
$0.157
-0.32%
1.3M
|
Health Technology
|
-93.72%
|
O:
-0.8%
H:
1.41%
C:
-4.03%
cancer
patent
Allogene Therapeutics Adds Renowned CAR T Expert, Jae Park, M.D. to its Scientific Advisory Board
Published:
2021-09-20
(Crawled : 14:00)
- biospace.com/
ALLO
|
$3.52
0.57%
0.57%
2.5M
|
Health Technology
|
-86.21%
|
O:
-2.72%
H:
1.94%
C:
0.77%
car-t
Autologous Cell Therapy Market analysis in Pharmaceuticals Industry | $ 4.11 Bn growth expected during 2021-2025 | 17,000+ Technavio Research Reports
Published:
2021-09-20
(Crawled : 13:15)
- prnewswire.com
BCLI
|
$0.5419
2.81%
2.73%
530K
|
Health Technology
|
-85.07%
|
O:
-1.13%
H:
0.0%
C:
-2.58%
therapy
growth
research
VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference
Published:
2021-09-20
(Crawled : 13:15)
- vynetherapeutics.com
VYNE
|
$2.41
-0.41%
-0.41%
31K
|
Health Technology
|
54.14%
|
O:
-4.46%
H:
2.0%
C:
-1.33%
conference
presentation
therapeutics
Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021
Published:
2021-09-20
(Crawled : 13:15)
- biospace.com/
LCTX
|
$1.29
12.17%
0.0%
2.3M
|
Health Technology
|
-54.9%
|
O:
-5.1%
H:
6.2%
C:
-2.89%
conference
Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit
Published:
2021-09-20
(Crawled : 13:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-80.43%
|
O:
-4.11%
H:
2.04%
C:
-3.67%
presentation
drug
Oncternal Therapeutics and Celularity Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published:
2021-09-20
(Crawled : 13:15)
- biospace.com/
CELU
|
$3.295
-5.86%
-6.22%
35K
|
|
-43.91%
|
O:
0.0%
H:
1.76%
C:
0.8%
ONCT
P
|
$8.71
0.23%
0.23%
4K
|
Health Technology
|
104.95%
|
O:
-5.66%
H:
2.5%
C:
-1.75%
collaboration
research
therapy
Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published:
2021-09-20
(Crawled : 13:15)
- biospace.com/
CELU
|
$3.295
-5.86%
-6.22%
35K
|
|
-43.91%
|
O:
0.0%
H:
1.76%
C:
0.8%
ONCT
P
|
$8.71
0.23%
0.23%
4K
|
Health Technology
|
104.95%
|
O:
-5.66%
H:
2.5%
C:
-1.75%
collaboration
research
therapy
Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published:
2021-09-20
(Crawled : 13:00)
- biospace.com/
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-46.95%
|
O:
-2.97%
H:
2.56%
C:
1.65%
fibrosis
positive
drug
preclinical
cudetaxestat
pre-clinical
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.